Understanding and evaluating the effects of implementing an electronic paediatric prescribing system on care

Albert Farre1, Carole Cummins2

  • 1Institute of Applied Health Research, University of Birmingham, Birmingham, UK Research and Development, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK.

BMJ Open
|February 5, 2016
PubMed

Insights

Implementing electronic paediatric prescribing (ePP) systems presents unique challenges in hospitals. This study explores staff perspectives and impacts of ePP on care provision and hospital work.

Area of Science:

  • Healthcare Informatics
  • Patient Safety
  • Pediatric Care

Background:

  • Electronic prescribing systems enhance healthcare quality and safety.
  • Paediatric prescribing involves complex dose calculations and manipulations, posing unique implementation challenges.
  • Understanding the organizational context is crucial for successful ePP system adoption.

Purpose of the Study:

  • To understand the organizational reality of introducing an electronic paediatric prescribing (ePP) system in a paediatric hospital.
  • To describe the changes associated with ePP implementation over time in paediatric wards.
  • To explore staff perspectives on ePP in relation to existing practices and assess its impact on care provision and hospital work.

Main Methods:

  • A qualitatively driven mixed-method approach incorporating ethnographic observation and interviews.
  • Substudy 1: Ethnographic research including non-participant observation and informal interviews.
  • Substudy 2: In-depth interviews and focus groups with healthcare professionals and managers.
  • Substudy 3: A quantitative staff survey administered pre- and post-implementation.

Main Results:

  • Analysis of ethnographic field notes and interview data to identify themes.
  • Descriptive statistics for survey data, with comparisons between baseline and follow-up.
  • Evaluation of ePP's impact on care provision and hospital work from multiple stakeholder perspectives.

Conclusions:

  • The study will provide insights into the complex implementation of ePP systems in paediatric settings.
  • Findings will inform strategies for optimizing ePP adoption and maximizing its benefits for patient safety and care quality.
  • Results will be disseminated through conferences, peer-reviewed journals, and feedback to clinical practice and policy development.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
39
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Methods of Documentation VII: EMR01:30

Methods of Documentation VII: EMR

Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
1.5K